世界のNSCLC治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global NSCLC Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4194 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、NSCLC治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口タイプ、注射タイプ）、用途別市場規模（扁平上皮肺癌、大細胞肺癌）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・NSCLC治療薬の市場動向 ・企業の競争状況、市場シェア ・NSCLC治療薬の種類別市場規模（経口タイプ、注射タイプ） ・NSCLC治療薬の用途別市場規模（扁平上皮肺癌、大細胞肺癌） ・NSCLC治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・NSCLC治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・NSCLC治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・NSCLC治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・NSCLC治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Bristol-Myers Squibb、Regeneron Pharmaceuticals、Novartis、Jiangsu Hengrui Medicine、Innovent Biologics、Shanghai Junshi Biosciences、BeiGene、Roche、AstraZeneca、Pfizer、Boehringer-Ingelheim、Teva） ・結論

Some cancer cells have gene changes (also called mutations) that help them grow and spread. The NSCLC Drugs is to block those changes.

Market Analysis and Insights: Global NSCLC Drugs Market
The global NSCLC Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NSCLC Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NSCLC Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NSCLC Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NSCLC Drugs market.

Global NSCLC Drugs Scope and Market Size
NSCLC Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global NSCLC Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Type
Injection Type

Segment by Application
Squamous Cell Lung Carcinoma
Large-cell Lung Carcinoma

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Bristol-Myers Squibb
Regeneron Pharmaceuticals
Novartis
Jiangsu Hengrui Medicine
Innovent Biologics
Shanghai Junshi Biosciences
BeiGene
Roche
AstraZeneca
Pfizer

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NSCLC Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Type
1.2.3 Injection Type
1.3 Market by Application
1.3.1 Global NSCLC Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Squamous Cell Lung Carcinoma
1.3.3 Large-cell Lung Carcinoma
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global NSCLC Drugs Market Perspective (2016-2027)
2.2 NSCLC Drugs Growth Trends by Regions
2.2.1 NSCLC Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 NSCLC Drugs Historic Market Share by Regions (2016-2021)
2.2.3 NSCLC Drugs Forecasted Market Size by Regions (2022-2027)
2.3 NSCLC Drugs Industry Dynamic
2.3.1 NSCLC Drugs Market Trends
2.3.2 NSCLC Drugs Market Drivers
2.3.3 NSCLC Drugs Market Challenges
2.3.4 NSCLC Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top NSCLC Drugs Players by Revenue
3.1.1 Global Top NSCLC Drugs Players by Revenue (2016-2021)
3.1.2 Global NSCLC Drugs Revenue Market Share by Players (2016-2021)
3.2 Global NSCLC Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by NSCLC Drugs Revenue
3.4 Global NSCLC Drugs Market Concentration Ratio
3.4.1 Global NSCLC Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NSCLC Drugs Revenue in 2020
3.5 NSCLC Drugs Key Players Head office and Area Served
3.6 Key Players NSCLC Drugs Product Solution and Service
3.7 Date of Enter into NSCLC Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 NSCLC Drugs Breakdown Data by Type
4.1 Global NSCLC Drugs Historic Market Size by Type (2016-2021)
4.2 Global NSCLC Drugs Forecasted Market Size by Type (2022-2027)

5 NSCLC Drugs Breakdown Data by Application
5.1 Global NSCLC Drugs Historic Market Size by Application (2016-2021)
5.2 Global NSCLC Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America NSCLC Drugs Market Size (2016-2027)
6.2 North America NSCLC Drugs Market Size by Type
6.2.1 North America NSCLC Drugs Market Size by Type (2016-2021)
6.2.2 North America NSCLC Drugs Market Size by Type (2022-2027)
6.2.3 North America NSCLC Drugs Market Size by Type (2016-2027)
6.3 North America NSCLC Drugs Market Size by Application
6.3.1 North America NSCLC Drugs Market Size by Application (2016-2021)
6.3.2 North America NSCLC Drugs Market Size by Application (2022-2027)
6.3.3 North America NSCLC Drugs Market Size by Application (2016-2027)
6.4 North America NSCLC Drugs Market Size by Country
6.4.1 North America NSCLC Drugs Market Size by Country (2016-2021)
6.4.2 North America NSCLC Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe NSCLC Drugs Market Size (2016-2027)
7.2 Europe NSCLC Drugs Market Size by Type
7.2.1 Europe NSCLC Drugs Market Size by Type (2016-2021)
7.2.2 Europe NSCLC Drugs Market Size by Type (2022-2027)
7.2.3 Europe NSCLC Drugs Market Size by Type (2016-2027)
7.3 Europe NSCLC Drugs Market Size by Application
7.3.1 Europe NSCLC Drugs Market Size by Application (2016-2021)
7.3.2 Europe NSCLC Drugs Market Size by Application (2022-2027)
7.3.3 Europe NSCLC Drugs Market Size by Application (2016-2027)
7.4 Europe NSCLC Drugs Market Size by Country
7.4.1 Europe NSCLC Drugs Market Size by Country (2016-2021)
7.4.2 Europe NSCLC Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific NSCLC Drugs Market Size (2016-2027)
8.2 Asia-Pacific NSCLC Drugs Market Size by Type
8.2.1 Asia-Pacific NSCLC Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific NSCLC Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific NSCLC Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific NSCLC Drugs Market Size by Application
8.3.1 Asia-Pacific NSCLC Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific NSCLC Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific NSCLC Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific NSCLC Drugs Market Size by Region
8.4.1 Asia-Pacific NSCLC Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific NSCLC Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America NSCLC Drugs Market Size (2016-2027)
9.2 Latin America NSCLC Drugs Market Size by Type
9.2.1 Latin America NSCLC Drugs Market Size by Type (2016-2021)
9.2.2 Latin America NSCLC Drugs Market Size by Type (2022-2027)
9.2.3 Latin America NSCLC Drugs Market Size by Type (2016-2027)
9.3 Latin America NSCLC Drugs Market Size by Application
9.3.1 Latin America NSCLC Drugs Market Size by Application (2016-2021)
9.3.2 Latin America NSCLC Drugs Market Size by Application (2022-2027)
9.3.3 Latin America NSCLC Drugs Market Size by Application (2016-2027)
9.4 Latin America NSCLC Drugs Market Size by Country
9.4.1 Latin America NSCLC Drugs Market Size by Country (2016-2021)
9.4.2 Latin America NSCLC Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa NSCLC Drugs Market Size (2016-2027)
10.2 Middle East & Africa NSCLC Drugs Market Size by Type
10.2.1 Middle East & Africa NSCLC Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa NSCLC Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa NSCLC Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa NSCLC Drugs Market Size by Application
10.3.1 Middle East & Africa NSCLC Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa NSCLC Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa NSCLC Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa NSCLC Drugs Market Size by Country
10.4.1 Middle East & Africa NSCLC Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa NSCLC Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck NSCLC Drugs Introduction
11.1.4 Merck Revenue in NSCLC Drugs Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb NSCLC Drugs Introduction
11.2.4 Bristol-Myers Squibb Revenue in NSCLC Drugs Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Regeneron Pharmaceuticals
11.3.1 Regeneron Pharmaceuticals Company Details
11.3.2 Regeneron Pharmaceuticals Business Overview
11.3.3 Regeneron Pharmaceuticals NSCLC Drugs Introduction
11.3.4 Regeneron Pharmaceuticals Revenue in NSCLC Drugs Business (2016-2021)
11.3.5 Regeneron Pharmaceuticals Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis NSCLC Drugs Introduction
11.4.4 Novartis Revenue in NSCLC Drugs Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Jiangsu Hengrui Medicine
11.5.1 Jiangsu Hengrui Medicine Company Details
11.5.2 Jiangsu Hengrui Medicine Business Overview
11.5.3 Jiangsu Hengrui Medicine NSCLC Drugs Introduction
11.5.4 Jiangsu Hengrui Medicine Revenue in NSCLC Drugs Business (2016-2021)
11.5.5 Jiangsu Hengrui Medicine Recent Development
11.6 Innovent Biologics
11.6.1 Innovent Biologics Company Details
11.6.2 Innovent Biologics Business Overview
11.6.3 Innovent Biologics NSCLC Drugs Introduction
11.6.4 Innovent Biologics Revenue in NSCLC Drugs Business (2016-2021)
11.6.5 Innovent Biologics Recent Development
11.7 Shanghai Junshi Biosciences
11.7.1 Shanghai Junshi Biosciences Company Details
11.7.2 Shanghai Junshi Biosciences Business Overview
11.7.3 Shanghai Junshi Biosciences NSCLC Drugs Introduction
11.7.4 Shanghai Junshi Biosciences Revenue in NSCLC Drugs Business (2016-2021)
11.7.5 Shanghai Junshi Biosciences Recent Development
11.8 BeiGene
11.8.1 BeiGene Company Details
11.8.2 BeiGene Business Overview
11.8.3 BeiGene NSCLC Drugs Introduction
11.8.4 BeiGene Revenue in NSCLC Drugs Business (2016-2021)
11.8.5 BeiGene Recent Development
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche NSCLC Drugs Introduction
11.9.4 Roche Revenue in NSCLC Drugs Business (2016-2021)
11.9.5 Roche Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca NSCLC Drugs Introduction
11.10.4 AstraZeneca Revenue in NSCLC Drugs Business (2016-2021)
11.10.5 AstraZeneca Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer NSCLC Drugs Introduction
11.11.4 Pfizer Revenue in NSCLC Drugs Business (2016-2021)
11.11.5 Pfizer Recent Development
11.12 Boehringer-Ingelheim
11.12.1 Boehringer-Ingelheim Company Details
11.12.2 Boehringer-Ingelheim Business Overview
11.12.3 Boehringer-Ingelheim NSCLC Drugs Introduction
11.12.4 Boehringer-Ingelheim Revenue in NSCLC Drugs Business (2016-2021)
11.12.5 Boehringer-Ingelheim Recent Development
11.13 Teva
11.13.1 Teva Company Details
11.13.2 Teva Business Overview
11.13.3 Teva NSCLC Drugs Introduction
11.13.4 Teva Revenue in NSCLC Drugs Business (2016-2021)
11.13.5 Teva Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global NSCLC Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Type
Table 3. Key Players of Injection Type
Table 4. Global NSCLC Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global NSCLC Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global NSCLC Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global NSCLC Drugs Market Share by Regions (2016-2021)
Table 8. Global NSCLC Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global NSCLC Drugs Market Share by Regions (2022-2027)
Table 10. NSCLC Drugs Market Trends
Table 11. NSCLC Drugs Market Drivers
Table 12. NSCLC Drugs Market Challenges
Table 13. NSCLC Drugs Market Restraints
Table 14. Global NSCLC Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global NSCLC Drugs Market Share by Players (2016-2021)
Table 16. Global Top NSCLC Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSCLC Drugs as of 2020)
Table 17. Ranking of Global Top NSCLC Drugs Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by NSCLC Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players NSCLC Drugs Product Solution and Service
Table 21. Date of Enter into NSCLC Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global NSCLC Drugs Market Size by Type (2016-2021) (US$ Million)
Table 24. Global NSCLC Drugs Revenue Market Share by Type (2016-2021)
Table 25. Global NSCLC Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global NSCLC Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global NSCLC Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global NSCLC Drugs Revenue Market Share by Application (2016-2021)
Table 29. Global NSCLC Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global NSCLC Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America NSCLC Drugs Market Size by Type (2016-2021) (US$ Million)
Table 32. North America NSCLC Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America NSCLC Drugs Market Size by Application (2016-2021) (US$ Million)
Table 34. North America NSCLC Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America NSCLC Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America NSCLC Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe NSCLC Drugs Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe NSCLC Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe NSCLC Drugs Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe NSCLC Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe NSCLC Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe NSCLC Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific NSCLC Drugs Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific NSCLC Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific NSCLC Drugs Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific NSCLC Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific NSCLC Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific NSCLC Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America NSCLC Drugs Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America NSCLC Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America NSCLC Drugs Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America NSCLC Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America NSCLC Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America NSCLC Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa NSCLC Drugs Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa NSCLC Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa NSCLC Drugs Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa NSCLC Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa NSCLC Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa NSCLC Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck NSCLC Drugs Product
Table 64. Merck Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Bristol-Myers Squibb Company Details
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb NSCLC Drugs Product
Table 69. Bristol-Myers Squibb Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million)
Table 70. Bristol-Myers Squibb Recent Development
Table 71. Regeneron Pharmaceuticals Company Details
Table 72. Regeneron Pharmaceuticals Business Overview
Table 73. Regeneron Pharmaceuticals NSCLC Drugs Product
Table 74. Regeneron Pharmaceuticals Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million)
Table 75. Regeneron Pharmaceuticals Recent Development
Table 76. Novartis Company Details
Table 77. Novartis Business Overview
Table 78. Novartis NSCLC Drugs Product
Table 79. Novartis Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Jiangsu Hengrui Medicine Company Details
Table 82. Jiangsu Hengrui Medicine Business Overview
Table 83. Jiangsu Hengrui Medicine NSCLC Drugs Product
Table 84. Jiangsu Hengrui Medicine Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million)
Table 85. Jiangsu Hengrui Medicine Recent Development
Table 86. Innovent Biologics Company Details
Table 87. Innovent Biologics Business Overview
Table 88. Innovent Biologics NSCLC Drugs Product
Table 89. Innovent Biologics Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million)
Table 90. Innovent Biologics Recent Development
Table 91. Shanghai Junshi Biosciences Company Details
Table 92. Shanghai Junshi Biosciences Business Overview
Table 93. Shanghai Junshi Biosciences NSCLC Drugs Product
Table 94. Shanghai Junshi Biosciences Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million)
Table 95. Shanghai Junshi Biosciences Recent Development
Table 96. BeiGene Company Details
Table 97. BeiGene Business Overview
Table 98. BeiGene Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million)
Table 99. BeiGene Recent Development
Table 100. Roche Company Details
Table 101. Roche Business Overview
Table 102. Roche NSCLC Drugs Product
Table 103. Roche Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million)
Table 104. Roche Recent Development
Table 105. AstraZeneca Company Details
Table 106. AstraZeneca Business Overview
Table 107. AstraZeneca NSCLC Drugs Product
Table 108. AstraZeneca Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million)
Table 109. AstraZeneca Recent Development
Table 110. Pfizer Company Details
Table 111. Pfizer Business Overview
Table 112. Pfizer NSCLC Drugs Product
Table 113. Pfizer Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million)
Table 114. Pfizer Recent Development
Table 115. Boehringer-Ingelheim Company Details
Table 116. Boehringer-Ingelheim Business Overview
Table 117. Boehringer-Ingelheim NSCLC Drugs Product
Table 118. Boehringer-Ingelheim Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million)
Table 119. Boehringer-Ingelheim Recent Development
Table 120. Teva Company Details
Table 121. Teva Business Overview
Table 122. Teva NSCLC Drugs Product
Table 123. Teva Revenue in NSCLC Drugs Business (2016-2021) & (US$ Million)
Table 124. Teva Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global NSCLC Drugs Market Share by Type: 2020 VS 2027
Figure 2. Oral Type Features
Figure 3. Injection Type Features
Figure 4. Global NSCLC Drugs Market Share by Application: 2020 VS 2027
Figure 5. Squamous Cell Lung Carcinoma Case Studies
Figure 6. Large-cell Lung Carcinoma Case Studies
Figure 7. NSCLC Drugs Report Years Considered
Figure 8. Global NSCLC Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global NSCLC Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global NSCLC Drugs Market Share by Regions: 2020 VS 2027
Figure 11. Global NSCLC Drugs Market Share by Regions (2022-2027)
Figure 12. Global NSCLC Drugs Market Share by Players in 2020
Figure 13. Global Top NSCLC Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NSCLC Drugs as of 2020
Figure 14. The Top 10 and 5 Players Market Share by NSCLC Drugs Revenue in 2020
Figure 15. Global NSCLC Drugs Revenue Market Share by Type (2016-2021)
Figure 16. Global NSCLC Drugs Revenue Market Share by Type (2022-2027)
Figure 17. North America NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America NSCLC Drugs Market Share by Type (2016-2027)
Figure 19. North America NSCLC Drugs Market Share by Application (2016-2027)
Figure 20. North America NSCLC Drugs Market Share by Country (2016-2027)
Figure 21. United States NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe NSCLC Drugs Market Share by Type (2016-2027)
Figure 25. Europe NSCLC Drugs Market Share by Application (2016-2027)
Figure 26. Europe NSCLC Drugs Market Share by Country (2016-2027)
Figure 27. Germany NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific NSCLC Drugs Market Share by Type (2016-2027)
Figure 35. Asia-Pacific NSCLC Drugs Market Share by Application (2016-2027)
Figure 36. Asia-Pacific NSCLC Drugs Market Share by Region (2016-2027)
Figure 37. China NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America NSCLC Drugs Market Share by Type (2016-2027)
Figure 45. Latin America NSCLC Drugs Market Share by Application (2016-2027)
Figure 46. Latin America NSCLC Drugs Market Share by Country (2016-2027)
Figure 47. Mexico NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa NSCLC Drugs Market Share by Type (2016-2027)
Figure 51. Middle East & Africa NSCLC Drugs Market Share by Application (2016-2027)
Figure 52. Middle East & Africa NSCLC Drugs Market Share by Country (2016-2027)
Figure 53. Turkey NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE NSCLC Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Merck Revenue Growth Rate in NSCLC Drugs Business (2016-2021)
Figure 57. Bristol-Myers Squibb Revenue Growth Rate in NSCLC Drugs Business (2016-2021)
Figure 58. Regeneron Pharmaceuticals Revenue Growth Rate in NSCLC Drugs Business (2016-2021)
Figure 59. Novartis Revenue Growth Rate in NSCLC Drugs Business (2016-2021)
Figure 60. Jiangsu Hengrui Medicine Revenue Growth Rate in NSCLC Drugs Business (2016-2021)
Figure 61. Innovent Biologics Revenue Growth Rate in NSCLC Drugs Business (2016-2021)
Figure 62. Shanghai Junshi Biosciences Revenue Growth Rate in NSCLC Drugs Business (2016-2021)
Figure 63. BeiGene Revenue Growth Rate in NSCLC Drugs Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in NSCLC Drugs Business (2016-2021)
Figure 65. AstraZeneca Revenue Growth Rate in NSCLC Drugs Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in NSCLC Drugs Business (2016-2021)
Figure 67. Boehringer-Ingelheim Revenue Growth Rate in NSCLC Drugs Business (2016-2021)
Figure 68. Teva Revenue Growth Rate in NSCLC Drugs Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---